1. Investors
    2. Investor Overview

    Investor Overview


    Quarterly Results

    Quarter 4

    Quarter 4

    Quarter 4

    Quarter 4

    Annual Reports

    Annual Report 2019 - 20

    Investor Presentation

    PPL - Acquisition of Hemmo Pharmaceuticals

    Corporate Governance

    Piramal Group is committed to creating value for its stakeholders by remaining steadfast in its core values.

    Stock Exchange Announcements

    PEL – Newspaper Advertisement – Information regarding 74th Annual General Meeting (‘AGM’) and Record Date for final dividend

    Event Calender

    Q4 & FY2021 Earnings Conference Call

    Investor Presentation

    Download

    © 2021 Piramal Enterprises Ltd.